As part of our £100,000 research investment for 2026, made possible by the generosity and commitment of our patient community, we are continuing to support bold, early-stage research that has the potential to transform outcomes for people living with neuroendocrine cancer. Delivered in partnership with UKINETS, these Pump Priming Grants fund innovative pilot projects designed to generate vital early evidence and pave the way for larger national and international studies.
Announcing a Pump Priming Grant Award Winner
We are pleased to award £30,000 to Prof. Martyn Caplin, Royal Free Hospital & University College London Hospital, for the project:
A cross-organ single-cell spatial atlas of neuroendocrine carcinoma using CosMx multiplexing
Lay Summary
Neuroendocrine carcinoma (NEC) is a rare and fast-growing cancer that can develop in different parts of the body and currently has limited treatment options. This research is based on the idea that many NECs, regardless of where they originate, may share common genetic abnormalities.
The project will analyse routine tumour biopsy samples using advanced technology that can measure the activity of thousands of genes within individual cancer cells. By identifying shared patterns across different NECs, the study aims to uncover new vulnerabilities that could be targeted by existing or future treatments, ultimately improving outcomes for patients.